Social isolation modulates corticotropin-releasing factor type 2 receptor, urocortin 1 and urocortin 2 mRNAs expression in the cardiovascular system of prairie voles

Peptides

Volumn 30, Issue 5, 2009, Pages 940-946

  Pournajafi Nazarloo, Hossein ^a   Partoo, Leila ^a   Sanzenbacher, Lisa ^a   Esmaeilzadeh, Maryam ^a   Paredes, Jamespaul ^a   Hashimoto, Kozo ^a   Azizi, Fereidoun ^a   Carter, C Sue ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cardiovascular system; CRF receptor; Isolation stress; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MESSENGER RNA; UROCORTIN I; UROCORTIN II;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROL GROUP; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; FEMALE; MALE; NONHUMAN; PRAIRIE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOCIAL ISOLATION;

ANIMALS; ARVICOLINAE; CORTICOSTERONE; FEMALE; MALE; MYOCARDIUM; RADIOIMMUNOASSAY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOCIAL ISOLATION; UROCORTINS;

ANIMALIA; MICROTUS OCHROGASTER;

EID: 67349205397     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.01.003     Document Type: Article

References (44)

1. Asaba K., Makino S., Nishiyama M., and Hashimoto K. Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin. J Cardiovasc Pharmacol 36 (2000) 493-497
2. Auffray C., and Rougeon F. Nucleotide sequence of a cloned cDNA corresponding to secreted mu chain of mouse immunoglobulin. Eur J Biochem 107 (1980) 303-314
3. Bale T.L., Giordano F.J., and Vale W.W. A new role for corticotropin-releasing factor receptor-2: suppression of vascularization. Trends Cardiovasc Med 13 (2003) 68-71
4. Bamberger C.M., Wald M., Bamberger A.M., Ergun S., Beil F.U., and Schulte H.M. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83 (1998) 708-711
5. Brar B.K., Jonassen A.K., Egorina E.M., Chen A., Negro A., Perrin M.H., et al. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145 (2004) 24-35
6. Cang C.P., Pearse R.I., O'Connell S., and Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11 (1993) 1187-1195
7. Carter C.S. Developmental consequences of oxytocin. Physiol Behav 79 (2003) 383-397
8. Carter C.S., DeVries A.C., and Getz L.L. Physiological substrates of mammalian monogamy: the prairie vole model. Neurosci Biobehav Rev 19 (1995) 303-314
9. Charles C.J., Rademaker M.T., and Richards A.M. Urocortins: putative role in cardiovascular disease. Curr Med Chem Cardiovasc Hematol Agents 2 (2004) 43-47
10. Coste S.C., Heldwein K.A., Stevens S.L., Tobar-Dupres E., and Stenzel-Poore M.P. IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology 142 (2001) 3537-3545
11. Das S., and O'Keefe J.H. Behavioral cardiology: recognizing and addressing the profound impact of psychosocial stress on cardiovascular health. Curr Atheroscler Rep 8 (2006) 111-118
12. Gardiner S.M., Kemp P.A., March J.E., Woolley J., and Bennett T. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Br J Pharmacol 125 (1998) 1543-1550
13. Gardiner S., March J., Kemp P., and Bennett T. A comparison between the cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin related peptide) in conscious rats. J Pharmacol Exp Ther 321 1 (2007) 221-226
14. Grippo A.J., Cushing B.S., and Carter C.S. Depression-like behavior and stressor-induced neuroendocrine activation in female prairie voles exposed to chronic social isolation. Psychosom Med 69 (2007) 149-157
15. Grippo A.J., Lamb D.G., Carter C.S., and Porges S.W. Cardiac regulation in the socially monogamous prairie vole. Physiol Behav 90 (2007) 386-393
16. Grippo A.J., Santos C.M., Johnson R.F., Beltz T.G., Martins J.B., Felder R.B., et al. Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am J Physiol Heart Circ Physiol 286 (2004) H619-H626
17. Heldwein K.A., Duncan J.E., Rittenberg M.B., Stenzel P., and Stenzel-Poore M.P. Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Mol Cell Endocrinol 31 (1997) 167-172
18. Heldwein K.A., Redick D.L., Rittenberg M.B., Claycomb W.C., and Stenzel-Poore M.P. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 137 (1996) 3631-3639
19. Hilakivi L.A., Ota M., and Lister R.G. Effects of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral 'despair'. Pharmacol Biochem Behav 33 (1989) 371-374
20. Hsu S.Y., and Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7 (2001) 605-611
21. Irvine R.J., White J., and Chan R. The influence of restraint on blood pressure in the rat. J Pharmacol Toxicol 38 (1997) 157-162
22. Kageyama K., Bradbury M.J., Zhao L., Blount A.L., and Vale W.W. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140 (1999) 5651-5658
23. Kageyama K., Gaudriault G.E., Bradbury M.J., and Vale W.W. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 141 (2000) 2285-2293
24. Keverne E.B., and Curley J.P. Vasopressin, oxytocin and social behaviour. Curr Opin Neurobiol 14 (2004) 777-783
25. Kishimoto T., Pearse R.V., Lin C.R., and Rosenfeld M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92 (1995) 1108-1112
26. Kostich W.A., Chen A., Sperle K., and Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol Endocrinol 12 (1998) 1077-1085
27. Krantz D.S., and McCeney M.K. Effects of psychological and social factors on organic disease: a critical assessment of research on coronary heart disease. Annu Rev Psychol 53 (2002) 341-369
28. Nazarloo H.P., Nishiyama M., Tanaka Y., Asaba K., and Hashimoto K. Down-regulation of corticotropin-releasing hormone receptor type 2beta mRNA expression in the rat cardiovascular system following food deprivation. Regul Pept 105 (2002) 121-129
29. Ng L.L., Loke I.W., O'Brien R.J., Squire I.B., and Davies J.E. Plasma urocortin in human systolic heart failure. Clin Sci 106 (2004) 383-388
30. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-471
31. Parkes D.G., Vaughan J., Rivier J., Vale W., and May C.N. Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol 272 (1997) H2115-H2122
32. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92 (1995) 2969-2973
33. Pournajafi-Nazarloo H., Partoo L., Sanzenbacher L., Azizi F., and Carter C.S. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress. Neuroendocrinology 86 (2007) 17-25
34. Pournajafi Nazarloo H., Takao T., Nanamiya W., Asaba K., De Souza E., and Hashimoto K. Effect of non-peptide corticotropin-releasing factor receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress. Brain Res 902 (2001) 119-126
35. Pournajafi Nazarloo H., Tanaka Y., Dorobantu M., and Hashimoto K. Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart. Regul Pept 115 (2003) 131-138
36. Rademaker M.T., Cameron V.A., Charles C.J., and Richards A.M. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 112 (2005) 3624-3632
37. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98 (2001) 2843-2848
38. Ruscio M.G., Sweeny T., Hazelton J., Suppatkul P., and Carter C.S. Social environment regulates corticotropin releasing factor, corticosterone and vasopressin in juvenile prairie voles. Horm Behav 51 (2007) 54-61
39. Smith M.J., Roovers E., Timmerman H., van de Vrede Y., Alewijinse A.E., and Leurs R. Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 → Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists. J Biol Chem 271 (1996) 7574-7582
40. Taymans S.E., DeVries A.C., DeVries M.B., Nelson R.J., Friedman T.C., Castro M., et al. The hypothalamic-pituitary-adrenal axis of prairie voles (Microtus ochrogaster): evidence for target tissue glucocorticoid resistance. Gen Comp Endocrinol 106 (1997) 48-61
41. Terui K., Higashiyama A., Horiba N., Furukawa K.I., Motomura S., and Suda T. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J Endocrinol 169 (2001) 177-183
42. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 (1995) 287-292
43. Weninger S.C., Peters L.L., and Majzoub J.A. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 141 (2000) 256-263
44. Yang L.Z., Kockskamper J., Heinzel F.R., Hauber M., Walther S., Spiess J., et al. Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A. Cardiovasc Res 69 (2006) 402-411